CareDx, Inc. · 5 hours ago
Senior Director, Sales & Commercial Excellence — CareDx Testing Services
United States
Full-time
Remote
Director/Executive
$318K/yr - $358K/yr
12+ years expCareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. The Senior Director, Sales & Commercial Excellence will build and scale the sales motions that drive Testing Services revenue growth and field effectiveness, ensuring compliance and governance across programs.
BiotechnologyHealth CareHealth DiagnosticsInformation Technology
No H1B
Responsibilities
Own the Sales & Commercial Excellence roadmap (Testing Services) aligning objectives, standards, and cadences for ABPs, Executive Exchanges, and Speaker Program activation
Establish governance (charters, RACI, SOPs, success criteria) and integrate with CareDx policies and code of conduct for compliant execution
Lead quarterly Commercial Excellence reviews with Sales Leadership, Marketing, Medical Affairs, Customer Experience, and Commercial Ops
Standardize Account Business Plan templates, quality standards, submission windows, and review cadences; drive adoption across regions/roles
Build and scale Executive Exchange forums with KOLs and C-suite stakeholders; define target lists, pre-read packs, meeting scripts, and outcomes trackers
Operationalize Speaker Programs (topic map, speaker bench, compliant invite & honoraria workflows) and measure pull-through to testing adoption
Partner with CT&D to embed Salesforce/Altify “Ways of Working” (stakeholder maps, opportunity plans, cadence dashboards) and reinforcement learning
Create field playbooks (territory planning, call cadences, data reviews) and coaching toolkits for RDs; integrate into Field Visits & Coaching Reports
Define KPI suites (ABP coverage/quality, executive exchange cadence & outcomes, speaker program ROI, adoption of WoW), plus Testing Services metrics (patient/test capture, tests-per-patient, QoQ growth, % paid tests)
Partner with Commercial Ops to deliver dashboards and scorecards for leaders and reps; run monthly readouts and corrective action plans
Ensure program SOPs follow CareDx compliance standards (conflicts of interest, interactions, documentation, and audit trails)
Coordinate with HR/Legal/Medical for speaker eligibility, content approval, and fair-market value processes
Orchestrate collaboration with Marketing, Medical Affairs, Customer Experience, Digital Solutions, Pharmacy, and Sales Ops to enable seamless account execution
Drive change management across regions through communication plans, training, lighthouse pilots, and scale-up governance
Qualification
Required
12+ years in Sales Excellence/Commercial Operations within diagnostics/medtech/biopharma; 5+ years leading national programs or field enablement
Deep familiarity with transplant ecosystem and health-system sales cycles; proven experience orchestrating cross-functional commercial programs
Expertise in CRM (Salesforce), Altify, analytics and dashboarding; strong program management and change leadership
Demonstrated ability to build compliant, scalable speaker and executive engagement programs
Exceptional communication, executive presence, and stakeholder management
Benefits
Health and welfare benefits, including a gym reimbursement program
401(k) savings plan match
Employee Stock Purchase Plan
Pre-tax commuter benefits
Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.
Company
CareDx, Inc.
CareDx, Inc., headquartered in South San Francisco, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$574.89MKey Investors
Bristol-Myers SquibbSprout Group
2021-01-21Post Ipo Equity· $164M
2020-06-09Post Ipo Equity· $117.1M
2018-11-13Post Ipo Equity· $52.8M
Leadership Team
John Hanna
President and CEO
Nathan Smith
Chief Financial Officer
Recent News
2026-01-16
2026-01-14
Company data provided by crunchbase